Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation

Pediatric Transplantation

Volumn 10, Issue 8, 2006, Pages 938-942

  Hasenbein, Wibke ^a   Albani, Johannes ^a   Englert, Cornelia ^a   Spehr, Aranke ^a   Grabhorn, Enke ^a   Kemper, Markus J ^a   Burdelski, Martin ^a   Ganschow, Rainer ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Calcineurin inhibitors; Children; Immunosuppression; Liver transplantation; Long term results

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TSUKUBAENOLIDE;

ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; ECZEMA; FEMALE; GINGIVA DISEASE; GLOMERULUS FILTRATION; GRAFT DYSFUNCTION; GRAFT REJECTION; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER DISEASE; LIVER TOXICITY; LIVER TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROPATHY; NEUROTOXICITY; PEDIATRIC SURGERY; QUALITY OF LIFE; RECIPIENT; TREATMENT OUTCOME;

CALCINEURIN; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 33750595685     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00580.x     Document Type: Article

References (18)

1. KELLY D. Optimal immunosuppression in teenagers. Pediatr Transplant 2002: 6: 480-487.
2. REDING R. Tacrolimus in pediatric liver transplantation. Pediatr Transplant 2002: 6: 447-451.
3. MARTIN SR, ATKISON P, ANAND R, et al. Studies of pediatric liver transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the USA and Canada. Pediatr Transplant 2004: 8: 273-283.
4. MC DIARMID SV, BUSUTTIL RW, ASHER NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995: 59: 530-536.
5. SHALEV A, NIR A, GRANOT E. Cardiac function in children post-orthotopic liver transplantation: Echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Pediatr Transplant 2005: 9: 18-22.
6. SCHWARTZ GJ, BRION LP, SPITZER A. Use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987: 34: 571-590.
7. DEMETRIS AJ, BATTS KP, DHILLON AP, et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997: 25: 658-663.
8. BECHSTEIN WO. Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transpl Int 2000: 13: 313-326.
9. KEMPER MJ, SPARTA G, LAUBE GF, MIOZZARI M, NEUHAUS TJ. Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation. Clin Transplant 2003: 17: 130-134.
10. LOO RM, ARIYARAJAH V, OH C, et al. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant recipients. Pediatr Transplant 2006: 10: 55-59.
11. HERZOG D, MARTIN S, TURPIN S, ALVAREZ F. Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 2006: 81: 672-677.
12. GANSCHOW R, SCHULZ T, MEYER T, et al. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients. J Pediatr Gastroenterol Nutr 2004: 38: 198-203.
13. REYES J, JAIN A, MAZARIEGOS G, et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 2000: 69: 2573-2580.
14. GREIG P, LILLY L, SCUDAMORE C, et al. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporine A trial: 1-year follow-up. Liver Transpl 2003: 9: 587-595.
15. DENTON MD, MAGEE CC, SAYEGH MH. Immunosuppressive strategies in transplantation. Lancet 1999: 353: 1083-1091.
16. YU S, WU L, JIN J, et al. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation 2006: 81: 46-51.
17. VENKATARAMANAN R, SWAMINATHAN A, PRASAD T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995: 29: 404-430.
18. GRABHORN E, SCHULZ A, HELMKE K, et al. Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 2004: 78: 235-241.